Saving NHS funding: Better medication management could save the NHS over...
NHS funding is at the forefront of national concern. Discover how PillTime Ltd. facilitates medication management to alleviate mounting pressure on existing resources.
Over 50%...
Science off the beaten track
Since 2004 the main interest of Jeanette Erdmann´s scientific work has been the identification of the genetic causes of coronary heart disease (CHD) and...
A mobile decision facilitator for oncology treatment
Christophe Vergne and Jean-Alexandre Kaminisky had known each other for a decade, working as competitors for many years, but they thought it was time...
Putting patients first by making cannabinoid medicinal products available
Tilray makes cannabinoid medicinal products available to patients in a time frame that matters and urges others to do the same
Focusing on patients, their...
The function of immune cells in combating cancer
The incidence of cancer has dramatically increased over the last 50 years as a result of prolonged life expectancy and the Western lifestyle. Recent...
Narratives in support of training for personalised healthcare
In the past, our health systems were established primarily to save lives. Emphasis was on correct clinical procedure for efficient and effective intervention, there...
How is data integrity changing?
David Thompson of Clarity Compliance Solutions Ltd explains why data integrity is not just about data risk assessments.
The issue of data integrity (DI) has...
The Matchmaker Exchange connects researchers and clinicians to identify novel Mendelian...
The Matchmaker Exchange (MME) was initiated in October 2013 as a community-organized effort to connect clinicians and researchers with rare cases. Matchmakers had evolved...
Key areas of research in the diagnosis and treatment of MPS...
Professor Dr François Eyskens of PCMA vzw discusses early diagnosis of MPS diseases by creating awareness and using a tandem mass spectrometry screening method.
MPS...
Advancing cannabinoid therapies through research
Canada’s medical cannabis company Tilray defines a medical path for cannabinoid use
Tilray is actively pursuing the daunting goal of delivering innovative, safe and effective...
Obesity treatment: a new efficient paradigm
Dr Holm Ltd. offers the web application DrHolmApp and educational courses for both healthcare professionals and patients.
Obesity is an immense global health challenge and...
The genetics of cardiovascular diseases
Cardiovascular diseases are the world’s biggest killers today, claiming the lives of almost 18 million people every year. Understanding what causes them and how...
Canada’s collaboration-based research strategy to face the challenge of dementia
Dementia – the new life thief
In the history of humanity, infectious diseases were once the great life thieves. Smallpox, black plague and tuberculosis robbed...
The Werther effect – the handling of suicide in the media
Vivien Kogler and Alexander Noyon from Mannheim University of Applied Sciences investigate suicidality as an important social subject and the role of medial presentation...
Asthma and issues
Researchers at the University Hospital Basel discuss developments in the diagnosis and treatment of asthma and allergies
Asthma is defined as a chronic inflammatory disease...
Aarhus University shares the merits of computational medicine
The Health Technology Program at Aarhus University applies computational biology to investigate the heterogeneity of tumours
Increasing computational power combined with enhanced access to imaging...
INOVA+ discusses the Organisational Life Assistant
INOVA+ discusses the Organisational Life Assistant – a virtual presence to provide a healthier, safer and more organised life for older adults
The European Commission’s...
Obesity – feeding the body or the mind?
Professor Dr Kerstin M Oltmanns of the University of Lübeck opens a new perspective on the epidemic of 2.2 billion overweight people
Obesity is a...
The origins of asthma
Led by Professor Hans Bisgaard, the COPSAC research unit focuses on phenotyping children and their environmental exposures to study asthma and other chronic inflammatory...
BPA in inoperable CTEPH patients
Chronic thromboembolic pulmonary hypertension (CTEPH) is a common form of pulmonary hypertension. Up to 5% of patients who survive acute pulmonary embolism will develop...